Scholarlink

<p>This study investigates the R&amp;D behavior of the world’s top R&amp;D investors during the Great Financial Crisis and the COVID-19 crisis. Focusing on the resilience of corporate R&amp;D activities, we explore two dimensions: stability and adaptability. Using two large datasets on the world’s leading R&amp;D-investing companies covering the periods 2004–2010 and 2015–2021, thus including both crises, our analysis reveals substantial heterogeneity in how top global R&amp;D-investing companies respond to economic downturns. Three patterns emerge: non-resilient companies (one-third), adaptive resilient companies that quickly recover after initial reductions (one-third), and stable resilient companies that maintain or expand R&amp;D throughout crises (one-third). Remarkably, this distribution remains consistent across both crises, suggesting generalizable response patterns among leading MNEs. However, the mechanisms driving these responses differ between crises. Pre-crisis sales growth consistently emerges as the strongest predictor of stable R&amp;D resilience in both crises, while pre-crisis profitability reinforces adaptive resilience, reflecting firms’ internal financing capabilities. Notably, resource reconfiguration capabilities—proxied by capital expenditure growth—positively influence stable resilience only during COVID-19, likely reflecting digital infrastructure investments that enabled distributed R&amp;D operations under mobility restrictions. Conversely, both high pre-crisis capex intensity and low profitability significantly increase the likelihood of non-resilient behavior, particularly during the 2009 GFC. We also identify significant regional and industry effects that vary between the two crises.</p>

错误：搜索内容不能为空，请输入英文关键词
错误：关键词超出字数限制，请精简
高级检索

Resilience of R&D of multinational companies: insights of two crises

  • 期刊论文

  • 出版模式：

    开放获取

  • 发表日期：

    2026年6月19日

查看全文
  • Heike Belitz,
  • Anna Lejpras

摘要

This study investigates the R&D behavior of the world’s top R&D investors during the Great Financial Crisis and the COVID-19 crisis. Focusing on the resilience of corporate R&D activities, we explore two dimensions: stability and adaptability. Using two large datasets on the world’s leading R&D-investing companies covering the periods 2004–2010 and 2015–2021, thus including both crises, our analysis reveals substantial heterogeneity in how top global R&D-investing companies respond to economic downturns. Three patterns emerge: non-resilient companies (one-third), adaptive resilient companies that quickly recover after initial reductions (one-third), and stable resilient companies that maintain or expand R&D throughout crises (one-third). Remarkably, this distribution remains consistent across both crises, suggesting generalizable response patterns among leading MNEs. However, the mechanisms driving these responses differ between crises. Pre-crisis sales growth consistently emerges as the strongest predictor of stable R&D resilience in both crises, while pre-crisis profitability reinforces adaptive resilience, reflecting firms’ internal financing capabilities. Notably, resource reconfiguration capabilities—proxied by capital expenditure growth—positively influence stable resilience only during COVID-19, likely reflecting digital infrastructure investments that enabled distributed R&D operations under mobility restrictions. Conversely, both high pre-crisis capex intensity and low profitability significantly increase the likelihood of non-resilient behavior, particularly during the 2009 GFC. We also identify significant regional and industry effects that vary between the two crises.